FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs
In a significant shift aimed at curbing soaring prescription drug prices in the United States, the Trump administration has announced…
Read more →
In a significant shift aimed at curbing soaring prescription drug prices in the United States, the Trump administration has announced…
Read more →
As the threat of a government shutdown looms, the future of the Supplemental Nutrition Assistance Program (SNAP) hangs in the…
Read more →
In a challenging year for Chipotle Mexican Grill, the fast-casual dining chain has seen its shares plummet by 33%, resulting…
Read more →
In a significant advancement in the healthcare technology sector, Dr. Clay Johnston, co-founder and chief medical officer of Harbor, has…
Read more →
Merck & Co., a leading global healthcare company, has recently adjusted its profit guidance for the fiscal year, citing a…
Read more →
In a competitive landscape dominated by the burgeoning market for GLP-1 receptor agonists, Eli Lilly is striving to maintain its…
Read more →
In a surprising turn of events in New York's political landscape, prominent figures including billionaire investor Bill Ackman, media mogul…
Read more →
In a recent address to investors, Comcast’s President Mike Cavanagh expressed a bullish outlook on mergers and acquisitions (M&A), asserting…
Read more →
In the wake of Chipotle Mexican Grill's recent third-quarter earnings report, several Wall Street analysts have adjusted their price targets…
Read more →
In a significant move to bolster its resilience against natural disasters, Jamaica has partnered with Aon to introduce a groundbreaking…
Read more →